Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

h_jud_2016a_2016-02-04t13:36:35z0 Hearing Summary

Date: 02/04/2016



Final

BILL SUMMARY for HB16-1054



HOUSE COMMITTEE ON JUDICIARY


Votes: View--> Action Taken:
Adopt amendment L.001 (Attachment NN). The motion

Adopt amendment L.002 (Attachment OO). The motion

Adopt amendment L.004 (Attachment PP). The motion

Adopt amendment L.005 (Attachment QQ). The motion

Adopt amendment L.006 (Attachment RR). The motion

Adopt amendment L.007 (Attachment SS). The motion

Adopt amendment L.009 (Attachment TT). The motion

Adopt amendment L.010 (Attachment UU). The motion

Adopt amendment L.011 (Attachment VV). The motion

Adopt amendment L.013 (Attachment WW). The motion

Refer House Bill 16-1054, as amended, to the Commi
PASS

PASS

PASS

PASS

PASS

PASS

PASS

PASS

PASS

PASS

PASS







01:37 PM -- HB16-1054



The committee was called to order. All members were present. Representative Kagan provided some information on how the day's proceedings would take place. Representatives Court and Ginal, prime sponsors presented House Bill 16-1054, concerning end-of-life options for individuals with a terminal illness. Representative Court discussed the merits of the bill. Representative Ginal explained the effect of the bill.





01:50 PM



Representative Ginal continued to brief the committee on the effect of HB 16-1054, and explained the effect of a number of forthcoming amendments. The following persons testified regarding HB 16-1054:



01:57 PM --
Mr. Roland Halpern, representing Compassionate Choices, testified in support of the bill. Mr. Halpern rebutted common arguments against legislation allowing the use of life-ending medication.



02:04 PM --
Mr. Chester Morgan, Representing Morgan Legal Offices, P.C., testified in opposition to the bill. Committee members received copies of Mr. Morgan's testimony (Attachment A). Mr. Morgan walked the committee through his objections to the bill as outlined in Attachment A. Mr. Morgan responded to questions regarding the potential for the bill to increase elder abuse, and the required relationship between witness and patient under the bill. Discussion ensued regarding the interplay between the bill and established probate law.



16HouseJud0204AttachA.pdf16HouseJud0204AttachA.pdf



02:19 PM



Mr. Morgan responded to questions regarding a provision in the bill requiring a physician to advise a patient of an end-of-life option in conjunction with a terminal diagnosis.



02:23 PM --
Dr. John Lobitz, representing himself, testified in support of HB 16-1054. Dr. Lobitz related his experience as a practicing physician in Oregon, which passed an end-of-life option bill during his practicing tenure. Dr. Lobitz responded to questions regarding how assisted suicide statistics are kept in Oregon. Dr. Lobitz continued to discuss his experiences.





02:33 PM



Discussion ensued regarding assisted suicide statistics in Oregon.



02:41 PM --
Ms. Margaret Dore, representing Choice is an Illusion, testified in opposition to the bill. Committee members received a brief in opposition to the bill (Attachment B), copies of a press release outlining Ms. Dore's objections to the bill (Attachment C), and another packet of information opposing the bill (Attachment D). Ms. Dore discussed some objections to the bill. Ms. Dore responded to questions regarding assisted suicides that have taken place in Washington under nefarious circumstances, where a death-with-dignity law is in effect, and assisted suicide data gathering in Oregon and Washington. Ms. Dore responded to questions regarding an anecdote she highlighted.



16HouseJud0204AttachB.pdf16HouseJud0204AttachB.pdf16HouseJud0204AttachC.pdf16HouseJud0204AttachC.pdf



16HouseJud0204AttachD.pdf16HouseJud0204AttachD.pdf



02:52 PM



Ms. Dore continued to respond to questions from the committee.



02:57 PM --
Ms. Joellyn Duesberry, representing herself, testified in support of HB 16-1054. Ms. Duesberry discussed her experiences as a cancer sufferer, and her reasons for supporting an end-of-life option. Discussion ensued regarding palliative care.



03:03 PM --
Ms. Carrie Ann Lucas, representing herself testified in opposition to the bill. Committee members received the testimony of Ms. Lucas (Attachment E), the testimony of Bruce Goguen and Robin Bolduc (Attachment F), and a briefing paper (Attachment G). Ms. Lucas responded to questions regarding certain medical cases she cited, and the insurance industry implications of extending an end-of-life option in law.



16HouseJud0204AttachE.pdf16HouseJud0204AttachE.pdf16HouseJud0204AttachF.pdf16HouseJud0204AttachF.pdf



16HouseJud0204AttachG.pdf16HouseJud0204AttachG.pdf



03:13 PM --
Dr. Dave Hibbard, representing himself testified in support of the bill. Dr. Hibbard related his experiences as a hospice doctor, and explained why an end-of-life option is needed. He related some examples of the benefits of such an option.



03:19 PM --
Dr. Bob Jotte, representing himself, testified in opposition to HB 16-1054. Dr. Jotte discussed the responsibilities of medical professionals to provide palliative and psychological care to terminal patients. Dr. Jotte responded to questions regarding the handling of death certificates of terminally ill patients, and the potential for misdiagnosis in terms of longevity outlook.





03:30 PM



Discussion returned to a doctor's obligations in verifying a death certificate, and the positions of medical professional organizations on the bill. Discussion ensued regarding the ability of patients to outlive longevity projections, and returned to the positions of medical professional organizations on HB 16-1054. The testimony of Alma Lantz was entered into the record (Attachment H). Dr. Jotte responded to questions regarding the medical professionals that must sign off on an end-of-life option under the bill.



16HouseJud0204AttachH.pdf16HouseJud0204AttachH.pdf



03:42 PM --
Chris Heinz, representing himself, testified in support of the bill. Mr. Heinz spoke of liberty issues for those with disabilities.



03:46 PM --
Dr. Kimberlie Jackson, representing the Colorado Cross-Disability Coalition, testified in opposition to the bill. Dr. Jackson discussed certain reservations with the bill.



03:50 PM --
Dr. Michael Allen, representing himself, testified in support of HB 16-1054. Dr. Allen spoke in support of personal freedom for patients, and addressed certain issued raised during earlier testimony.



03:53 PM --
Mr. Preston Branaugh, representing himself, testified in opposition to the bill. Mr. Branaugh discussed certain terms associated with the bill, and the witness requirements of the bill. Mr. Branaugh responded to questions regarding the potential impact of the bill on future hospice options. Discussion ensued regarding the potential for building certain safeguards for patients into the bill.





04:05 PM



Mr. Branaugh responded to questions regarding the handling of unused medication under the bill, and certain legal terms associated with the bill.



04:09 PM --
Dr. Bill Bolthouse, representing himself, testified in opposition to HB 16-1054. Dr. Bolthouse discussed changes in the medical profession, and explained how the bill changes the profession negatively. Discussion ensued regarding the ethics of the medical profession. Dr. Bolthouse discussed experiences with assisted suicide laws in other countries.



04:17 PM --
Dr. Cory Carroll, representing himself, testified in support of the bill. Committee members received an outline of Dr. Carroll's testimony (Attachment I). Dr. Carroll reviewed the outline for the committee.



16HouseJud0204AttachI.pdf16HouseJud0204AttachI.pdf



04:21 PM --
Mr. Michael Norton, representing the Colorado Freedom Institute, testified in opposition to the bill. Committee members received copies of Mr. Norton's testimony (Attachment J). Mr. Norton highlighted this testimony. Discussion ensued regarding a "slippery slope" based on Oregon's end-of-life law.



16HouseJud0204AttachJ.pdf16HouseJud0204AttachJ.pdf



04:26 PM --
Dr. David Schrier, representing himself, testified in support of HB 16-1054. Dr. Schrier discussed the difficulties that terminally ill patients experience, and spoke in favor of individual choice. Dr. Schrier responded to questions regarding certain objections raised about the bill during earlier testimony. Discussion ensued regarding the difference between terminal and chronic illnesses, and how these different types of illnesses are managed. The testimony of Jeff Frant was entered into the record (Attachment K).



16HouseJud0204AttachK.pdf16HouseJud0204AttachK.pdf



04:36 PM



Dr. Schrier responded to questions regarding how an end-of-life option might be managed under HB 16-1054 and the rate at which people in Oregon who were prescribed end-of-life medication that decide to use it.





04:45 PM



Dr. Schrier responded to questions about the procedure for prescribing end-of-life medication. Representative Court distributed information on Oregon's Death With Dignity Act (Attachment L). Representative Ginal informed the committee of additional sources of data collection. Dr. Schrier discussed safeguards in place to protect people from undue influence.



16HouseJud0204AttachL.pdf16HouseJud0204AttachL.pdf



04:58 PM --
The testimony of Ms. Renee Walbert was entered into the record (Attachment M).



16HouseJud0204AttachM.pdf16HouseJud0204AttachM.pdf



04:59 PM --
Ms. Patty James, representing herself and Compassionate Choices, testified in support of the bill. Committee members received copies of Ms. James' testimony (Attachment N). Ms. James discussed her experiences with her father, who was diagnosed with a terminal illness and wished to have an end-of-life option. Ms. James explained that she has lung cancer and wants an end-of-life option.



16HouseJud0204AttachN.pdf16HouseJud0204AttachN.pdf



05:04 PM --
Dr. Michelle Stanford, representing herself, testified in opposition to HB 16-1054. Committee members received copies of Dr. Stanford's testimony (Attachment O). Dr. Stanford read her testimony. Dr. Stanford responded to questions about the potential impact of passing the bill on the overall suicide rate. A comparison was drawn with marijuana legalization in Colorado and its effect on adolescent marijuana use.



16HouseJud0204AttachO.pdf16HouseJud0204AttachO.pdf



05:18 PM



Dr. Stanford continued to respond to questions from the committee.



05:19 PM --
Mr. James Sack, representing himself, testified in support of the bill. Mr. Sack urged the committee to work on certain issues and pass the bill. He asked for an end-of-life option.



05:24 PM --
Dr. Lauri Costello, representing herself and Compassionate Choices, testified in support of HB 16-1054. Dr. Costello clarified some terms surrounding the debate over the bill, and addressed certain reservations raised about the bill during previous testimony. Dr. Costello responded to questions regarding how left over end-of-life drugs are disposed of in Washington. Committee members received copies of Dr. Costello's testimony (Attachment P). The testimony of the Reverend Doctor Pamela Griffin Law was entered into the record (Attachment Q).



16HouseJud0204AttachP.pdf16HouseJud0204AttachP.pdf16HouseJud0204AttachQ.pdf16HouseJud0204AttachQ.pdf



05:30 PM



The committee recessed.





06:02 PM



The committee returned to order.



06:06 PM --
Mr. Brad Bergford, representing the Colorado Chapter of the National Lawyers Association and the Commission for the Protection of Constitutional Rights, testified in opposition to the bill. Mr. Bergford's testimony was entered into the record (Attachment R). Mr. Bergford read his testimony to the committee. Mr. Bergford responded to questions regarding constitutional challenges to end-of-life laws in other states.



16HouseJud0204AttachR.pdf16HouseJud0204AttachR.pdf



06:11 PM --
Ms. Melissa Brenkert, representing herself, testified in support of the bill. Ms. Brenkert discussed her experiences when her sister was dying of a terminal illness.



06:16 PM --
Ms. Jill Romann, Douglas County Coroner, testified in opposition to the bill. Ms. Romann discussed the spread of suicide. Ms. Romann responded to questions regarding the Werther Effect, and the suicide rate in Colorado.



06:22 PM --
Mr. Chad Kenney, representing himself, testified in support of the bill. Mr. Kenney discussed his experiences with the loss of loved ones to terminal illness, both of whom ended their lives.



06:27 PM --
Ms. Dawn Russel, representing herself, testified in opposition to HB 16-1054. She explained that the bill will put certain vulnerable populations at risk. Ms. Russel related an anecdote about a program that allows people to move away from nursing homes and into the community.



06:34 PM --
Ms. Jody Engelstad, representing herself, testified in support of the bill. Ms. Engelstad recounted the deterioration of her mother's quality of life toward the end of her life, and her mother's desire to have her suffering end.



06:37 PM --
Dr. John Volk, representing himself, testified in opposition to HB 16-1054. Dr. Volk discussed the implications of an end-of-life bill on a desire to keep down health care costs, and the cultural implications of such legislation.



06:41 PM --
Dr. Charles Lobitz, representing himself, testified in support of the bill. Committee members received written testimony from Dr. Lobitz (Attachment S). Dr. Lobitz addressed claims made during earlier testimony.



16HouseJud0204AttachS.pdf16HouseJud0204AttachS.pdf



06:46 PM --
Mr. Josh Winkler, representing the Colorado Cross-Disability Coalition, testified in opposition to the bill. Mr. Winkler registered some specific objections to the bill as drafted, detailing specific provisions.



06:51 PM --
Nancy Stalker, representing herself, testified in support of HB 16-1054. Ms. Stalker discussed the choices facing those with terminal illnesses.



06:55 PM --
Dr. Ken Stone, representing himself, testified in opposition to the bill. Committee members received copies of Dr. Stone's testimony (Attachment T). Dr. Stone read his testimony to the committee. Dr. Stone responded to questions regarding the ramifications of taking an improper dose of an end-of-life drug, and evidence that the application of these drugs in Oregon has resulted in unintended consequences. Discussion ensued regarding the application of life-ending drugs.



16HouseJud0204AttachT.pdf16HouseJud0204AttachT.pdf



07:08 PM



Discussion continued regarding the application of life-ending drugs.



07:08 PM --
Ms. Linda King, representing herself, testified in support of the bill. Committee members received copies of Ms. King's testimony (Attachment U). Ms. King read her testimony to the committee. Ms. King commented on the drugs used for end-of-life purposes.



16HouseJud0204AttachU.pdf16HouseJud0204AttachU.pdf



07:13 PM --
Ms. Cara Jean Reimann, representing herself and the Colorado Cross-Disability Coalition, testified in opposition to the bill. Ms. Reimann discussed certain terms associated with the end-of-life debate. Ms. Reimann responded to questions regarding the use of "terminal illness" in the bill, and its potential conflation with "disability."



07:24 PM --
Dr. Jerry Gilbert, representing Compassionate Choices, testified in support of the bill. Committee members received copies of Mr. Gilbert's testimony (Attachment V). Dr. Gilbert read his testimony to the committee.



16HouseJud0204AttachV.pdf16HouseJud0204AttachV.pdf



07:28 PM --
Dr. Alan Rastrelli, representing himself, testified in opposition to the bill. Dr. Rastrelli questioned how Oregon measures abuse of its end-of-life law, and discussed potential complications in administering end-of-life drugs. Dr. Rastrelli responded to questions regarding how Oregon tracks reporting associated with its end-of-life law, and oversight of drug administration.





07:45 PM



Dr. Rastrelli continued to respond to questions from the committee.



07:55 PM --
Mr. Brian Blakely, representing himself, testified in support of the bill. Mr. Blakely discussed the bill in terms of individual freedom.



08:00 PM --
Mr. Michael Neil, representing the Colorado Cross-Disability Coalition, testified in opposition to HB 16-1054. Committee members received a collection of articles assembled by Mr. Neil (Attachment W). Mr. Neil used his own health issues as an example of why he opposes the bill.



16HouseJud0204AttachW.pdf16HouseJud0204AttachW.pdf



08:05 PM --
Mr. John Spangler, representing himself, testified in support of the bill. Ms. Spangler discussed the humanitarian aspects of the bill, and recounted the passing of his wife.



08:10 PM --
Dr. Scott Bowman, representing himself, testified in opposition to the bill. Dr. Bowman questioned the uncivil aspects of having doctors prescribe life-taking drugs. He questioned the compassionate nature of the bill. Discussion ensued regarding the definitions of civilization and compassion.



08:17 PM --
Mr. Lance Wright, representing himself, testified in support of the bill. Mr. Wright discussed the liberty and small government aspects of HB 16-1054, and noted that he will be sponsoring a ballot issue to place an end-of-life measure in the Colorado Constitution. Mr. Wright responded to questions regarding a physician's right to refuse to administer a life-ending drug under the bill.



08:24 PM --
Ms. Fran Maes, representing herself, testified in opposition to HB 16-1054. Ms. Maes discussed her aunt's decision to end her life due to an illness, which she recanted. Committee members received a packet of information pertaining to her aunt (Attachment X).



16HouseJud0204AttachX.pdf16HouseJud0204AttachX.pdf



08:29 PM --
Ms. Elaine Selsberg, representing herself, testified in support of the bill. Ms. Selsberg discussed the end-of-life decisions of her father, which were impacted by a terminal disease.



08:34 PM --
Dr. Carolyn Ackerman, representing herself, testified in opposition to the bill. Dr. Ackerman read a statement outlining her opposition to the legislation, discussing end-of-life issues.



08:38 PM --
Ms. Julie Selsberg, representing herself, testified in support of the bill. Mr. Selsberg discussed an editorial her late father wrote to the Denver Post seeking an end-of-life option, and recounted the loss of her father.



08:44 PM --
Ms. Dawn Howard, representing herself and the Colorado Cross-Disability Coalition, testified in opposition to HB 16-1054. Ms. Howard explained that the bill does not provide safeguards for those with disabilities, and explained that prognoses can wrong.



08:46 PM --
Ms. Bebe Epstein, representing herself, testified in support of HB 16-1054. Ms. Epstein recounted the loss of her husband to a terminal illness.



08:49 PM --
Ms. Julie Farrar, representing herself, testified in opposition to the bill. Ms. Farrar discussed the potential impact of the bill on vulnerable populations, and recounted a situation during which she acted as power of attorney for someone who suffered from a terminal illness.



08:54 PM --
Mr. Lewis Daniels, representing himself, testified in support of the bill. Committee members received copies of Mr. Daniels' testimony (Attachment Y). Mr. Daniels read his testimony to the committee.



16HouseJud0204AttachY.pdf16HouseJud0204AttachY.pdf



08:57 PM --
Ms. Tiffany Boranosky, representing the Hospice and Palliative Care Association of the Rockies, testified in opposition to HB 16-1054. Ms. Boranosky explained that her organization currently opposes the bill, but may move to a position of neutrality if certain amendments are added to the bill. Ms. Boranosky responded to questions regarding the desire of her patients to exercise an end-of-life option like that offered in the bill.



09:01 PM --
Ms. Joan Sterns, representing herself, testified in support of the bill. Committee members received copies of Ms. Sterns' testimony (Attachment Z). Ms. Sterns read her testimony to the committee.



16HouseJud0204AttachZ.pdf16HouseJud0204AttachZ.pdf



09:03 PM --
Ms. Sandra Mayea-Llosa, representing herself, testified in opposition to the bill. Ms. Mayea-Llosa recounted the loss of her friends and loved ones, and explained the benefits received through hospice care. Ms. Mayea-Llosa entered the testimony of Dr. Kenneth Dernovsek into the record (Attachment AA).



16HouseJud0204AttachAA.pdf16HouseJud0204AttachAA.pdf



09:08 PM --
Dr. Rosalitha Moye, representing herself, testified in support of HB 16-1054. Dr. Moye objected to the term "physician-assisted suicide," and noted support within the medical community for end-of-life legislation. Dr. Moye discussed the impact of medical progress on the desire for an end-of-life option.



09:13 PM --
Ms. Lexi Tsoi, representing herself, testified in opposition to bill. Ms. Tsoi, a medical student, discussed the duty of medical professionals to their patients, and supported a better alternative to the bill. Ms. Tsoi entered the testimony of Dr. Kim Dernovsek into the record (Attachment BB). Ms. Tsoi responded to a question from the committee about her studies.



16HouseJud0204AttachBB.pdf16HouseJud0204AttachBB.pdf



09:19 PM --
Ms. Louisa Ritsick, representing herself, testified in support of HB 16-1054. Ms. Ritsick discussed safeguards that can be structured to prevent probate-related abuses. Ms. Ritsick responded to questions regarding how her probate clients demonstrate their competence. Ms. Ritsick responded to questions regarding her position on the bill in terms of the need for amending the legislation.



09:31 PM --
Mr. Tom Uebbing, representing himself, testified in opposition to the bill. Mr. Uebbing discussed the consequences of principles, and explained how this applies to the bill.



09:38 PM --
Mr. Ed Hanks, representing Colorado Right to Life, testified in opposition to the bill. Mr. Hanks discussed the potential normalization of suicide by the passage of such legislation, as well as the potential for the legislation to lead to "mercy killing." Mr. Hanks discussed potential unethical practices that may take place under HB 16-1054.



09:41 PM --
Dr. Oswald Garagorry, representing himself, testified in opposition to the bill. Dr. Garagorry discussed the need to preserve American and Colorado heritage.



09:45 PM --
Mr. Scott Horak, representing Americans United for Life, testified in opposition to the bill. Mr. Horak discussed certain constitutional ramifications of passing HB 16-1054.



09:51 PM --
Ms. Sylvia Talkington, representing herself, testified in opposition to the bill. Ms. Talkington discussed a potential breech of medical ethics on the part medical professionals should they conduct activities authorized by the bill, and discussed a potential slippery slope resulting from the bill's passage.



09:54 PM --
Mr. Jeffrey Johnson, representing himself, testified in opposition to the bill. Mr. Johnson recounted the loss of his wife to a terminal illness, and discussed the issue of end-of-life dignity. Mr. Johnson discussed suffering.



09:59 PM --
Ms. Deborah Dooley, representing herself, testified in opposition to the bill. Ms. Dooley discussed the lack of accountability for physicians in HB 16-1054, and the potential for abuses to take place under this law. Ms. Dooley quoted Biblical scripture.



10:03 PM --
Dr. Francisco LaRosa, representing himself, testified in opposition to HB 16-1054. Dr. LaRosa discussed conditional variability among patients, and explained that end-of-life diagnoses are difficult. He explained how this subjectivity bears on the bill. Dr. LaRosa responded to questions regarding how to safeguard against the abuse of an end-of-life option.



10:11 PM --
Ms. Laura Thomas, representing herself, testified in opposition to HB 16-1054. Ms. Thomas outlined three objections to the bill. Ms. Thomas then read a statement in opposition to the bill. Ms. Thomas responded to questions regarding the potential for amending the bill to address an issue she raised about the authorization of a death certificate under the bill. Discussion ensued regarding the implications of the bill in terms of a coroner's inquest. Discussion followed regarding the potential for end-of-life drugs to be improperly handled or disposed of under HB 16-1054.



10:28 PM --
Mr. Halpern returned to address certain concerns raised during previous testimony. The following written testimony was entered into the record: Bev Bishop (Attachment CC), Sandy Mandel (Attachment DD), Janet Brazill (Attachment EE), Ronald Braun (Attachment FF), Dee Sweeney (Attachment GG), Beverly Sparks (Attachment HH), Ruth Guy (Attachment II), Larry Hofer (Attachment JJ), Lynn Weitzel (Attachment KK), Joan Stearns (Attachment LL), and Whitey Powers (Attachment MM).



16HouseJud0204AttachCC.pdf16HouseJud0204AttachCC.pdf16HouseJud0204AttachDD.pdf16HouseJud0204AttachDD.pdf



16HouseJud0204AttachEE.pdf16HouseJud0204AttachEE.pdf16HouseJud0204AttachFF.pdf16HouseJud0204AttachFF.pdf



16HouseJud0204AttachGG.pdf16HouseJud0204AttachGG.pdf16HouseJud0204AttachHH.pdf16HouseJud0204AttachHH.pdf



16HouseJud0204AttachII.pdf16HouseJud0204AttachII.pdf16HouseJud0204AttachJJ.pdf16HouseJud0204AttachJJ.pdf



16HouseJud0204AttachKK.pdf16HouseJud0204AttachKK.pdf16HouseJud0204AttachLL.pdf16HouseJud0204AttachLL.pdf



16HouseJud0204AttachMM.pdf16HouseJud0204AttachMM.pdf





10:33 PM



Representative Kagan explained the effect of amendment L.001 (Attachment NN).



16HouseJud0204AttachNN.pdf16HouseJud0204AttachNN.pdf

BILL: HB16-1054
TIME: 10:34:16 PM
MOVED: Kagan
MOTION: Adopt amendment L.001 (Attachment NN). The motion passed on a vote of 6-5.
SECONDED: Lee
VOTE
Carver
No
Court
Yes
Dore
No
Foote
Yes
Lawrence
No
Lundeen
No
Melton
Yes
Salazar
Yes
Willett
No
Lee
Yes
Kagan
Yes
YES: 6 NO: 5 EXC: 0 ABS: 0 FINAL ACTION: PASS





10:36 PM



Representative Kagan explained the effect of amendment L.002 (Attachment OO).



16HouseJud0204AttachOO.pdf16HouseJud0204AttachOO.pdf

BILL: HB16-1054
TIME: 10:36:26 PM
MOVED: Kagan
MOTION: Adopt amendment L.002 (Attachment OO). The motion passed on a vote of 6-5.
SECONDED: Lee
VOTE
Carver
No
Court
Yes
Dore
No
Foote
Yes
Lawrence
No
Lundeen
No
Melton
Yes
Salazar
Yes
Willett
No
Lee
Yes
Kagan
Yes
YES: 6 NO: 5 EXC: 0 ABS: 0 FINAL ACTION: PASS





10:40 PM



Representatives Ginal and Court explained the effect of amendment L.004 (Attachment PP). Discussion ensued regarding the impact of the amendment on a physician's certification of death under the bill, and what might constitute the cause of death when the end-of-life option is exercised under the amendment.



16HouseJud0204AttachPP.pdf16HouseJud0204AttachPP.pdf



11:01 PM



Discussion continued regarding the implications of amendment L.004 on the issuing of a death certificate under the bill. Ms. Christy Chase, Office of Legislative Legal Services, provided input on the issues raised by amendment L.004.

BILL: HB16-1054
TIME: 10:40:59 PM
MOVED: Court
MOTION: Adopt amendment L.004 (Attachment PP). The motion passed on a vote of 6-5.
SECONDED: Lee
VOTE
Carver
No
Court
Yes
Dore
No
Foote
Yes
Lawrence
No
Lundeen
No
Melton
Yes
Salazar
Yes
Willett
No
Lee
Yes
Kagan
Yes
YES: 6 NO: 5 EXC: 0 ABS: 0 FINAL ACTION: PASS





11:08 PM



Representative Ginal explained the effect of amendment L.005 (Attachment QQ).



16HouseJud0204AttachQQ.pdf16HouseJud0204AttachQQ.pdf

BILL: HB16-1054
TIME: 11:09:16 PM
MOVED: Court
MOTION: Adopt amendment L.005 (Attachment QQ). The motion passed on a vote of 6-5.
SECONDED: Melton
VOTE
Carver
No
Court
Yes
Dore
No
Foote
Yes
Lawrence
No
Lundeen
No
Melton
Yes
Salazar
Yes
Willett
No
Lee
Yes
Kagan
Yes
YES: 6 NO: 5 EXC: 0 ABS: 0 FINAL ACTION: PASS





11:10 PM



Representative Ginal explained the effect of amendment L.006 (Attachment RR).



16HouseJud0204AttachRR.pdf16HouseJud0204AttachRR.pdf

BILL: HB16-1054
TIME: 11:10:59 PM
MOVED: Court
MOTION: Adopt amendment L.006 (Attachment RR). The motion passed on a vote of 6-5.
SECONDED: Melton
VOTE
Carver
No
Court
Yes
Dore
No
Foote
Yes
Lawrence
No
Lundeen
No
Melton
Yes
Salazar
Yes
Willett
No
Lee
Yes
Kagan
Yes
YES: 6 NO: 5 EXC: 0 ABS: 0 FINAL ACTION: PASS





11:12 PM



Representative Court explained the effect of amendment L.007 (Attachment SS).



16HouseJud0204AttachSS.pdf16HouseJud0204AttachSS.pdf

BILL: HB16-1054
TIME: 11:12:39 PM
MOVED: Court
MOTION: Adopt amendment L.007 (Attachment SS). The motion passed on a vote of 9-2.
SECONDED: Melton
VOTE
Carver
Yes
Court
Yes
Dore
Yes
Foote
Yes
Lawrence
Yes
Lundeen
No
Melton
Yes
Salazar
Yes
Willett
No
Lee
Yes
Kagan
Yes
YES: 9 NO: 2 EXC: 0 ABS: 0 FINAL ACTION: PASS





11:14 PM



Representative Melton explained the effect of amendment L.009 (Attachment TT). Discussion ensued regarding a provision in the bill that allows a request for aid-in-dying medication to be witnessed by an heir.



16HouseJud0204AttachTT.pdf16HouseJud0204AttachTT.pdf

BILL: HB16-1054
TIME: 11:15:29 PM
MOVED: Melton
MOTION: Adopt amendment L.009 (Attachment TT). The motion passed on a vote of 6-5.
SECONDED: Salazar
VOTE
Carver
No
Court
Yes
Dore
No
Foote
Yes
Lawrence
No
Lundeen
No
Melton
Yes
Salazar
Yes
Willett
No
Lee
Yes
Kagan
Yes
YES: 6 NO: 5 EXC: 0 ABS: 0 FINAL ACTION: PASS





11:18 PM



Representative Melton explained the effect of amendment L.010 (Attachment UU).



16HouseJud0204AttachUU.pdf16HouseJud0204AttachUU.pdf

BILL: HB16-1054
TIME: 11:19:23 PM
MOVED: Melton
MOTION: Adopt amendment L.010 (Attachment UU). The motion passed on a vote of 6-5.
SECONDED: Salazar
VOTE
Carver
No
Court
Yes
Dore
No
Foote
Yes
Lawrence
No
Lundeen
No
Melton
Yes
Salazar
Yes
Willett
No
Lee
Yes
Kagan
Yes
YES: 6 NO: 5 EXC: 0 ABS: 0 FINAL ACTION: PASS





11:22 PM



Representative Salazar explained the effect of amendment L.011 (Attachment VV). Discussion ensued regarding restrictions against offering amendments over one page in length that have not been distributed to the committee one day in advance.



16HouseJud0204AttachVV.pdf16HouseJud0204AttachVV.pdf

BILL: HB16-1054
TIME: 11:22:51 PM
MOVED: Lee
MOTION: Adopt amendment L.011 (Attachment VV). The motion passed on a vote of 6-5.
SECONDED: Salazar
VOTE
Carver
No
Court
Yes
Dore
No
Foote
Yes
Lawrence
No
Lundeen
No
Melton
Yes
Salazar
Yes
Willett
No
Lee
Yes
Kagan
Yes
YES: 6 NO: 5 EXC: 0 ABS: 0 FINAL ACTION: PASS





11:26 PM



Representative Salazar explained the effect of amendment L.013 (Attachment WW). Discussion ensued regarding whether the nature of the amendment is optional or mandatory. Representative Ginal responded to questions regarding whether returned end-of-life medications are taken into state control.



16HouseJud0204AttachWW.pdf16HouseJud0204AttachWW.pdf

BILL: HB16-1054
TIME: 11:26:27 PM
MOVED: Salazar
MOTION: Adopt amendment L.013 (Attachment WW). The motion passed on a vote of 7-4.
SECONDED: Melton
VOTE
Carver
No
Court
Yes
Dore
Yes
Foote
Yes
Lawrence
No
Lundeen
No
Melton
Yes
Salazar
Yes
Willett
No
Lee
Yes
Kagan
Yes
YES: 7 NO: 4 EXC: 0 ABS: 0 FINAL ACTION: PASS





11:32 PM



Representatives Court and Ginal provided closing remarks in support of HB 16-1054. Various committee members provided their positions on the bill.

BILL: HB16-1054
TIME: 11:33:41 PM
MOVED: Court
MOTION: Refer House Bill 16-1054, as amended, to the Committee of the Whole. The motion passed on a vote of 6-5.
SECONDED: Lee
VOTE
Carver
No
Court
Yes
Dore
No
Foote
Yes
Lawrence
No
Lundeen
No
Melton
Yes
Salazar
Yes
Willett
No
Lee
Yes
Kagan
Yes
Final YES: 6 NO: 5 EXC: 0 ABS: 0 FINAL ACTION: PASS







11:53 PM



The committee adjourned.


COVID-19 Resources

Temporary Guidelines for Review and Comment Meetings

The House and Senate are temporarily adjourned. The building is closed to the public.